UNLIMITED TURBO LONG - MERCK & CO. Stock

Certificat

0DILB

NLBNPNL2DNJ8

Market Closed - Euronext Paris 12:30:01 2024-05-21 pm EDT
3.997 EUR -0.99% Intraday chart for UNLIMITED TURBO LONG - MERCK & CO.
Current month-0.54%
1 month+11.09%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-21 3.997 -0.99%
24-05-20 4.037 +1.89%
24-05-17 3.962 -0.97%
24-05-16 4.001 +1.24%
24-05-15 3.952 +4.91%

Real-time Euronext Paris

Last update May 21, 2024 at 12:30 pm EDT

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
0DILB
ISINNLBNPNL2DNJ8
Date issued 2023-05-30
Strike 88.72 $
Maturity Unlimited
Parity 10 : 1
Emission price 2.59
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 4.365
Lowest since issue 1.36
Spread 0.006
Spread %0.15%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
131 USD
Average target price
141.6 USD
Spread / Average Target
+8.13%
Consensus
  1. Stock Market
  2. Certificates
  3. 0DILB Certificat
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW